Integumen PLC (SKIN) Company Profile - CorporateInformation.com

Integumen PLC Company Snapshot

Integumen PLC operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Integumen PLC with three other companies in this sector in UNITED KINGDOM : Physiomics PLC (2018 sales of £428,277.00 [US$528,086.95 ] of which 100% was Outsourced Systems and Computational Bio), Realm Therapeutics PLC (£190,410.34 [US$234,785.47 ] of which 100% was Drug Development and Wound care), and Redx Pharma PLC (£129,000.00 [US$159,063.45 ] of which 100% was pharmaceutical).

Sales Analysis.

Integumen PLC

Stock Data:

Recent Stock Performance:

Current Price (5/22/2020): 1.75p
(Figures in Pounds Sterling)

1 Week	11.1%	13 Weeks	40.0%

4 Weeks	19.5%	52 Weeks	-11.8%

Integumen PLC Key Data:

Ticker:	SKIN	Country:	Ireland

Exchanges:	LON	Major Industry:	Commercial Services & Supplies

		Sub Industry:	Commercial Physical Research

2018 Sales	274,000 (Year Ending Jan 2019).	Employees:	N/A

Currency:	Pounds Sterling	Market Cap:	18,767,296

Fiscal Yr Ends:	December	Shares Outstanding:	1,072,416,903

Share Type:	Ordinary	Closely Held Shares:	433,996,093

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.